Lyme disease is the most common tick-borne infectious disease in the United States. There is no vaccine to protect against it in humans. Biopharmaceutical company Pfizer and Valne ...

Drugmakers are working on a potential new shot to prevent the tick-borne illness. How might it fare in the era of vaccine skepticism?

Since pharmaceutical companies Pfizer and Valneva announced positive results from their phase 3 trial of a vaccine to prevent Lyme disease last month, two questions have loomed large: Will the vaccine ...

Pfizer has announced that its new Lyme disease vaccine reduced the rate of infection by more than 70 percent in a recent trial. This is a notable achievement as an estimated 476,000 Americans contract ...

DUNCANSVILLE, Pa. (AP) — Researchers are seeking thousands of volunteers in the U.S. and Europe to test the first potential vaccine against Lyme disease in 20 years -- in hopes of better fighting the ...

The pharmaceutical companies testing out a new Lyme disease vaccine said Monday they plan to seek approvals from the federal government even though the latest clinical trial results were not as ...

Amid the alarming rise in tick-borne diseases, particularly here in New England, researchers are working on promising approaches to better protect people while they spend time outdoors. Technologies ...

Scientists developing vaccines and anti-tick treatments amid growing concern over spread of disease Cases of Lyme disease have risen more than 20% in England in the past year, public health experts ...

Pfizer and Valenva are seeking regulatory approval from the Food and Drug Administration for a Lyme disease vaccine in development that's more than 70% effective against the tick-borne illness.